Treatment of Prostatitis
For acute bacterial prostatitis, treat with fluoroquinolones (or broad-spectrum IV antibiotics if severely ill) for an adequate duration; for chronic prostatitis/chronic pelvic pain syndrome, use a multimodal approach starting with alpha-blockers if voiding symptoms are present, avoiding repeated antibiotics unless infection is documented, and incorporating pelvic floor physical therapy, pain management, and lifestyle modifications. 1, 2
Acute Bacterial Prostatitis (ABP)
Pathogen Profile
Enterobacterales are the primary causative organisms 1. This is a potentially serious infection with risk for urosepsis requiring prompt treatment.
Treatment Algorithm
For severely ill patients:
- Start IV broad-spectrum antibiotics immediately 3
- Options include:
- Third-generation cephalosporins PLUS aminoglycoside
- Fluoroquinolones PLUS aminoglycoside
- Broad-spectrum penicillins PLUS aminoglycoside
- Use piperacillin-tazobactam or meropenem if multidrug-resistant gram-negative pathogens are suspected 3
For stable outpatients:
- Fluoroquinolones are first-line (e.g., ciprofloxacin, levofloxacin) 3, 4
- Duration: Adequate course (typically 2-4 weeks minimum) 3, 5
Critical Pitfall
Do not underestimate severity—ABP can rapidly progress to urosepsis. Obtain blood cultures and urine cultures before starting antibiotics 1.
Chronic Bacterial Prostatitis (CBP)
Key Distinction
CBP involves documented recurrent urinary tract infections with the same bacterial strain 6. This represents <10% of all prostatitis cases 1.
Pathogen Spectrum
- Enterobacterales remain most common 1
- Broader spectrum than ABP, including atypical organisms 1
- Consider sexually transmitted infections (Chlamydia trachomatis, Mycoplasma genitalium) in appropriate clinical context 3
Treatment Approach
Antimicrobial therapy:
- Fluoroquinolones for 2-4 weeks cure approximately 70% of CBP cases 3
- For Chlamydial prostatitis: Macrolides are more effective than fluoroquinolones 3
- Doxycycline 100 mg twice daily for 7 days is equally effective as macrolides for intracellular pathogens 3
- For quinolone-resistant cases: Consider aminoglycosides or fosfomycin 3
Important Caveat: Only use antibiotics when infection is microbiologically documented. Repeated empiric antibiotic courses without positive cultures should be avoided 7.
Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)
Critical Context
This represents 90% of prostatitis cases 8. The etiology is multifactorial and largely non-infectious, involving neuroinflammation and chronic pain mechanisms 2. The pain often derives from neurologic origins rather than tissue injury 2.
Classification System
Use the UPOINTS algorithm to phenotype patients 3:
- Urinary symptoms
- Psychosocial factors
- Organ-specific findings
- Infection (if documented)
- Neurological/systemic factors
- Tenderness of pelvic floor muscles
- Sexual dysfunction (present in 46-92% of cases) 3
Treatment Algorithm
First-Line Interventions
1. Alpha-Blockers (if voiding LUTS present):
- In CP/CPPS patients with voiding symptoms, offer alpha-blocker treatment 2
- Options: Alfuzosin, doxazosin, silodosin, tamsulosin 0.4 mg daily, terazosin 2, 9
- Mechanism: Reduces functional bladder outlet obstruction 9, 3
- Evidence shows symptom reduction and improved quality of life 9, 3
- Greatest benefit occurs within first 45 days of treatment 9
2. Lifestyle Modifications:
- Dietary changes: Avoid spicy foods, coffee, tea, chili, alcohol (47% of patients report food sensitivities) 2
- Increase fruits, vegetables, water, herbal teas; avoid processed foods 2
- Aerobic exercise 2
- Consider referral to dietician 2
3. Pelvic Floor Physical Therapy:
- Essential component for patients with pelvic floor muscle tenderness 2
- Addresses muscle tension contributing to pain 2
Second-Line Options
Pain Management:
- Simple analgesics initially 3
- NSAIDs can reduce symptoms but long-term use limited by side effects 3
- Early consideration of neuropathic pain medications (e.g., gabapentin, pregabalin, tricyclic antidepressants) for non-responders 7
Multimodal Combination:
- Concurrent use of alpha-blockers, antibiotics (if infection documented), and anti-inflammatories shows better symptom control than single-drug treatment 3
Phytotherapy:
- Quercetin, pollen extract, Serenoa repens extracts show positive effects on symptoms and quality of life without significant side effects 3
- Can be used as primary therapy or adjunct 3
When to Avoid Antibiotics
Do NOT use repeated courses of fluoroquinolones or other antibiotics in CP/CPPS unless:
- Bacterial infection is microbiologically documented 7
- There is clear symptomatic benefit from infection control 7
The utility of empiric antimicrobial trials in CP/CPPS remains debatable since infectious etiology is unclear 8, 5.
Specialist Referral Indications
Refer early (do not wait for multiple failed treatments) if:
- No response to first-line measures 7
- Significant neuropathic pain component 7
- Psychological comorbidities requiring cognitive behavioral therapy 7
- Sexual dysfunction requiring specialist management 7
Multidisciplinary Team Approach
Optimal management involves 7:
- Urologists
- Pain specialists
- Pelvic floor physiotherapists
- Cognitive behavioral therapists/psychologists
- Sexual health specialists
- Primary care physicians for coordination
Patient Education Essentials
- CP/CPPS is a chronic pain condition, not primarily an infection
- Pain can originate from nerve dysfunction, not just tissue damage
- Treatment may not achieve complete cure but can significantly improve quality of life
- Chronic pain cycle mechanisms and importance of multimodal approach
- Realistic expectations about treatment timeline and outcomes
Common Pitfalls to Avoid
- Overuse of antibiotics in culture-negative CP/CPPS 7
- Delayed referral to pain specialists or physical therapy 7
- Ignoring sexual dysfunction component (affects nearly half of patients) 3
- Failure to address psychological factors early 7
- Not considering dysbiosis/gut-prostate axis in refractory cases 3